Physician profile
Peter M Bess
NPI 1558560961
$1,510.02
in general payments reported to CMS, 2019-2025
16 companies · $216 in 2025
The $216 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $238 · 2021: $321 · 2022: $228 · 2023: $156 · 2024: $188 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $332.00 | 2019-2021 | |
| Tris Pharma INC | $299.27 | 2019-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $132.29 | 2021-2024 | Qelbree, Qelbree |
| Corium, LLC | $116.76 | 2022-2023 | Azstarys |
| Seqirus USA INC | $103.13 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Adlon Therapeutics L.P. | $91.11 | 2020-2021 | |
| Glaxosmithkline, LLC. | $71.76 | 2019-2023 | Pediarix, Bexsero |
| Pfizer INC. | $69.58 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $61.93 | 2024-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Ironshore Pharmaceuticals INC. | $57.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $50.77 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $40.65 | 2021-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $31.86 | 2024 | |
| Sanofi Pasteur INC. | $19.80 | 2024 | |
| Alk-Abello, INC | $16.72 | 2025 | Neffy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $15.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.